This is where we share what's happening at MeetPositives — new features, platform improvements, community milestones, and company announcements. Since launching in 2013, MeetPositives has grown into one of the most trusted dating communities for positive singles globally, and we're committed to continuing to improve the experience for every member. Follow this section to stay current on what's new, what's coming, and how we're responding to member feedback. Have a suggestion or a story to share? Reach out via our support center — we read everything.
In the PURPOSE 5 trial, 85.6% of people starting twice-yearly lenacapavir stayed on schedule for a year, versus 46.3% on daily PrEP pills. Here is what the study found, what it did not test, and what it means for dating.
Read More →
Final week-104 data from the AMP trials show the VRC01 antibody kept blocking highly sensitive HIV strains, but resistant breakthrough infections rose after infusions ended. Here is what that means, and what it does not, for dating and prevention.
Read More →
Ohio Health Modernization Movement is holding its first Advocacy Day at the Statehouse on Nov. 17 to modernize six HIV criminal laws. Prosecutions have hit hundreds of people living with HIV—often regardless of transmission risk. Here's why disclosure laws still shape dating.
Read More →
A federal judge struck down a CMS rule that would have required people with HIV and other conditions to prove their illness limits their ability to work to stay exempt from Medicaid work requirements. What changed, what didn't, and why it matters for staying undetectable.
Read More →
The FDA tentatively approved the first generic version of lenacapavir, the twice-yearly HIV prevention shot, at $40 a year for 120 lower-income countries. Why it matters, why it can't be sold in the U.S. and what it means for mixed-status dating.
Read More →
The FDA granted accelerated approval to Voceryq, the first U.S. plasmid DNA-based immunotherapy, for adults with recurrent respiratory papillomatosis caused by HPV 6 and 11. What the study showed, what it doesn't mean and why HPV stays manageable in dating.
Read More →
Canada's top public health officer reports infectious syphilis up more than fourfold since 2014, gonorrhea tripled and HIV diagnoses still elevated. Here's how U.S. STI trends compare and what it means for testing and dating.
Read More →
WHO vaccine advisers now favor a single HPV vaccine dose for girls 9 to 14, but people living with HIV should still get at least two. Here is what changed, what a new Lancet HIV study shows, what U.S. HIV guidelines say, and what it means for dating.
Read More →
UC Davis Health performed its first kidney transplant from a donor with HIV to a recipient with HIV. Here's how the HOPE Act and 2024 rules opened this path, what the research shows, and what it means for people living with HIV.
Read More →